Patient Capital Management's Q2 2024 investor letter highlighted their underperformance compared to the S&P 500, citing allocation and interaction effects. Everi Holdings Inc. was mentioned as a promising investment, with shares experiencing fluctuations. The firm emphasized a focus on AI stocks for higher returns.